Terms: = Kidney tumors AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Treatment
15 results:
1. Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis.
Zhang X; Wu Y; Wang D
BMC Infect Dis; 2024 Jan; 24(1):10. PubMed ID: 38166695
[TBL] [Abstract] [Full Text] [Related]
2. Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC).
Donovan EK; Xie F; Louie AV; Chu W; Siva S; Kapoor A; Swaminath A
Clin Genitourin Cancer; 2022 Oct; 20(5):e353-e361. PubMed ID: 35490099
[TBL] [Abstract] [Full Text] [Related]
3. A Clinical Decision Aid to Support Personalized treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis.
Psutka SP; Gulati R; Jewett MAS; Fadaak K; Finelli A; Legere L; Morgan TM; Pierorazio PM; Allaf ME; Herrin J; Lohse CM; Houston Thompson R; Boorjian SA; Atwell TD; Schmit GD; Costello BA; Shah ND; Leibovich BC
Eur Urol; 2022 Jun; 81(6):576-585. PubMed ID: 34862099
[TBL] [Abstract] [Full Text] [Related]
4. Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
Fuchs CS; Shitara K; Di Bartolomeo M; Lonardi S; Al-Batran SE; Van Cutsem E; Ilson DH; Alsina M; Chau I; Lacy J; Ducreux M; Mendez GA; Alavez AM; Takahari D; Mansoor W; Enzinger PC; Gorbounova V; Wainberg ZA; Hegewisch-Becker S; Ferry D; Lin J; Carlesi R; Das M; Shah MA;
Lancet Oncol; 2019 Mar; 20(3):420-435. PubMed ID: 30718072
[TBL] [Abstract] [Full Text] [Related]
5. Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma.
Zhang F; Xie Y; Ma X; Gu L; Li H; Li X; Guo G; Zhang X
Urol Oncol; 2019 Mar; 37(3):184.e9-184.e17. PubMed ID: 30509867
[TBL] [Abstract] [Full Text] [Related]
6. Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice.
Thiery-Vuillemin A; Cholley T; Calcagno F; Hugues M; Maurina T; Limat S; Nguyen Tan Hon T; Almotlak H; Mouillet G; Nerich V
Clin Genitourin Cancer; 2018 Apr; 16(2):e297-e305. PubMed ID: 29066073
[TBL] [Abstract] [Full Text] [Related]
7. Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
Wan YP; Xi M; He HC; Wan S; Hua W; Zen ZC; Liu YL; Zhou YL; Mo RJ; Zhuo YJ; Luo HW; Jiang FN; Zhong WD
Oncol Res Treat; 2017; 40(1-2):15-20. PubMed ID: 28118628
[TBL] [Abstract] [Full Text] [Related]
8. Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma.
Bharwani N; Miquel ME; Powles T; Dilks P; Shawyer A; Sahdev A; Wilson PD; Chowdhury S; Berney DM; Rockall AG
Br J Cancer; 2014 Feb; 110(3):616-24. PubMed ID: 24366299
[TBL] [Abstract] [Full Text] [Related]
9. Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma.
May M; Brookman-Amissah S; Pflanz S; Roigas J; Hoschke B; Kendel F
Br J Radiol; 2009 Aug; 82(981):724-31. PubMed ID: 19255117
[TBL] [Abstract] [Full Text] [Related]
10. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract] [Full Text] [Related]
11. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract] [Full Text] [Related]
12. Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure.
Modarresifar H; Almodovar S; Bass WB; Ojha B
Health Phys; 2007 Feb; 92(2 Suppl):S45-9. PubMed ID: 17228187
[TBL] [Abstract] [Full Text] [Related]
13. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.
Zisman A; Wieder JA; Pantuck AJ; Chao DH; Dorey F; Said JW; Gitlitz BJ; deKernion JB; Figlin RA; Belldegrun AS
J Urol; 2003 Mar; 169(3):909-16. PubMed ID: 12576811
[TBL] [Abstract] [Full Text] [Related]
14. Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place.
Wagner JR; Walther MM; Linehan WM; White DE; Rosenberg SA; Yang JC
J Urol; 1999 Jul; 162(1):43-5. PubMed ID: 10379736
[TBL] [Abstract] [Full Text] [Related]
15. treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study.
D'Angio GJ; Breslow N; Beckwith JB; Evans A; Baum H; deLorimier A; Fernbach D; Hrabovsky E; Jones B; Kelalis P
Cancer; 1989 Jul; 64(2):349-60. PubMed ID: 2544249
[TBL] [Abstract] [Full Text] [Related]
